Growth and leadership Datacubed Health has recently appointed a new CEO (Kyle Hogan) and a new CTO (Vikram Natarajan) in 2024, signaling a strategic leadership refresh that could open conversations about scale, governance, and enterprise partnerships with sponsors seeking seasoned management.

Awarded patient focus The company received MedTech Breakthrough awards for Best Mobile App for Patient Engagement in 2024, highlighting a strong value proposition around patient-centric digital trial experiences that can be leveraged to win sponsors prioritizing engagement and retention metrics.

Global expansion A notable international footprint includes a 2023 China platform launch and collaborations with global partners, suggesting opportunities to position Datacubed Health for multinational trials and region-specific deployments.

Diverse clinical capabilities Their platform covers Decentralized Trials, eCOA/ePRO, telehealth, eConsent, medication adherence, and geofencing, enabling cross-sell across trial phases and functions for sponsors looking to consolidate vendors and streamline data capture.

Strong data and tech stack With a revenue range of 25–50 million and 44 million in funding, plus a tech stack including SAS, Docker, Salesforce, and WordPress, Datacubed presents an investable profile for tiered enterprise deployments, external integrations, and scalable analytics partnerships.